SHANGHAI – This year's China Healthcare Investment Conference (CHIC) event, where investors and entrepreneurs gathered between the mirrored walls of the Ritz-Carlton, was especially supercharged, thanks to the recent decision by the Hong Kong Stock Exchange to open its doors to pre-revenue biotech companies, a move that has the potential to usher in a new era of wealth and opportunity for many of the attendees.